Symptomatic Therapy for Patients With Huntington's Disease

NCT04071639 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Huntington Disease

Interventions

DRUG: Haloperidol 2Mg Tab
DRUG: Risperidone 1Mg Tab
DRUG: Zoloft 50Mg Tablet
DRUG: Idebenone
DRUG: Deutetrabenazine Oral Tablet [Austedo]

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University